Observatory · observe first
Lilly (Eli)
LLY · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
0.758%
12M weight contribution
+0.252 pp
3M weight contribution
+0.340 pp
12M price return
+67.8%
Share of matched S&P 500 members
Monthly observations through Feb 2019
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Feb 2019 | $130.8bn | 0.758% | +0.252 pp | +67.8% | Yes |
| Jan 2019 | $127.0bn | 0.419% | -0.093 pp | +50.9% | Yes |
| Dec 2018 | $122.6bn | 0.438% | -0.073 pp | +45.6% | Yes |
| Nov 2018 | $125.7bn | 0.418% | -0.094 pp | +49.3% | No |
| Oct 2018 | $116.5bn | 0.395% | -0.117 pp | +35.8% | No |
| Sep 2018 | $115.3bn | 0.367% | -0.144 pp | +34.4% | No |
| Aug 2018 | $113.5bn | 0.366% | -0.145 pp | +32.3% | No |
| Jul 2018 | $106.1bn | 0.619% | +0.107 pp | +23.1% | Yes |
| Jun 2018 | $92.6bn | 0.562% | +0.050 pp | +6.3% | Yes |
| May 2018 | $92.3bn | 0.560% | +0.049 pp | +5.9% | Yes |
| Apr 2018 | $88.0bn | 0.541% | +0.029 pp | +0.3% | Yes |
| Mar 2018 | $84.8bn | 0.520% | +0.009 pp | -4.3% | Yes |
| Feb 2018 | $84.4bn | 0.506% | -0.006 pp | -4.7% | No |
| Jan 2018 | $89.7bn | 0.512% | +0.000 pp | +0.0% | No |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.